QED Biomedical Ltd. provide Systematic, Mapping & Rapid Reviews of data from early stage pre-clinical and biomedical studies

We are pioneering evidence based methods to combat low attrition rates, the reproducibility crisis, stealth research and publication bias

We can help you identify the risks in early biotechnology innovations; providing optimal decision making

We can assist with due diligence. Identifying the reproducibility and validity of new biomedical technologies

We can help identify the knowledge base in an area of new innovation or for repurposing.